fashion -WSS

fashion

author：focus 2025-09-29 18:17:53 - browse：3627

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Scrutiny of post

WSS

4th of July breaks record for highest global temperature ever measured

When is a doctor not a doctor? Try when patients address women doctors

Biogen joins immunology wave with $1.15 billion acquisition of HI

Meta looks to target Twitter with a rival app called Threads

ASCO eve: Let’s set the table for this year's meeting

Doctor appointment wait times are getting worse

hotspot

fashion

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Inside the fall of star MIT scientist David Sabatini

Medicare details structure of new drug price negotiation program

ASCO eve: Let’s set the table for this year's meeting

ChatGPT in medicine: STAT answers readers' burning questions

These geoengineering technologies could help combat the climate crisis, scientists say

Heart attack and stroke risk calculators need revising

Can food be medicine? And other questions about a new push

Bright Health sells Medicare Advantage business to Molina

As a primary care physician, here's how I hope to partner with AI

hotspot

Bird flu surveillance in wastewater gets boost from consortium

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Community addresses injustice for Long Island mothers

FDA poised to publish guidelines for clinical trial diversity

FDA poised to publish guidelines for clinical trial diversity

Questions and answers about ramping up H5N1 bird flu vaccine

hotspot

focus

entertainment

hotspot